Effect of Bifidobacterium animalis subsp lactis Supplementation in Preterm Infants: A Systematic Review of Randomized Controlled Trials

2010-08
Systematic Review
Journal of Pediatric Gastroenterology and Nutrition 51(2)
- H. Szajewska
- S. Guandalini
- L. Morelli
- J. V. van Goudoever
- A. Walker

PubMed: 20543719
DOI: 10.1097/MPG.0b013e3181dc0d93

30 Insights on

Reduced Intestinal Permeability

High evidence

It also can [...] decrease intestinal permeability.

Effect: Beneficial
Effect size: Moderate

Bifidobacterium animalis subsp. lactis XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.

2022-06-08
Clinical Trial
Food & Function 13(11)
- Baofeng Xu
- Shengnan Liang
- Jiayi Zhao
- Xuetong Li
- Jiayao Guo
- Bowen Xin
- Bailiang Li
- G. Huo
- Weiwei Ma

PubMed: 35616024
DOI: 10.1039/d1fo04305f

29 Insights on

Reduced Intestinal Permeability

Low evidence
Animal Study
Clinical

*B. lactis* XLTG11 reduced the pathological characteristics of the intestinal tract, and significantly reduced the levels of lipopolysaccharide (LPS), D-lactic acid (D-LA) and diamine oxidase (DAO) to decrease intestinal permeability.

Effect: Beneficial
Effect size: Moderate
Significant: Yes